Psychedelic drug R&D is ramping up rapidly. The number of past and current clinical studies on these substances will surprise you.
Articles
Pharmadrug Inc. Provides Update on Debt Restructuring
PharmaDrug is restructuring approximately $1 million in debt in the form of convertible debentures.
ATAI Life Sciences acquiring Kures to develop novel therapeutics for opioid abuse
Atai Life Sciences is bolstering its R&D platform with the acquisition of New York-based Kures.
Legalizing Medicinal Use of Psilocybin on Oregon’s November Ballot
Oregon could become the first U.S. state to LEGALIZE the (medicinal) use of a psychedelic drug.
Psychedelics Investing 101: the Drug Approval Process and Drug Patents
Understanding the drug approval process that leads to drug patents and drug licensing is of critical importance for successful investing in psychedelics.
Osoyoos Provides Corporate Update on AI Pharma Acquisition
Osoyoos Cannabis provides additional details on its previously announced acquisition.
IntelGenx and Cybin Corp Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film
Cybin Corp is partnering with IntelGenx Corp to produce a new delivery system for pharmaceutical-grade psilocybin.
Mydecine Innovations Group Adds 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to Its Scientific Advisory Board
Mydecine's new Scientific Advisor holds over 150 U.S. and international patents and will oversee Mydecine's mycology lab.
Mydecine Adds Biotech Heavy-Hitter To Science Team
Mydecine Innovations Group has added one of the world's pre-eminent biotech scientists to its Scientific Advisory Board.
Hinterland to Acquire Novamind Ventures Inc
Novamind Ventures Inc. is preparing to go public via amalgamation with unlisted public company, Hinterland Metals Inc.
Looking For The Perfect Inflation Hedge? Try This Company
Inflation is rapidly eroding our purchasing power and consuming our wealth. Here is a powerful antidote for investors.
CannaGlobal, Sansero Life Sciences and Rise Wellness To Merge, Creating a New International Psychedelics Company
Three private companies are merging to create a new entity in the psychedelics space.
The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
Red Light Holland Names Medical and Scientific Division
Red Light Holland makes move into medicinal psychedelic applications.
Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million
Hollister Biosciences announces a private placement for CAD$1.5 million, expected to close by July 12, 2020.